Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Synthetic Blood International Inc. Stories

2008-07-01 09:01:11

Effective today, Oxygen Biotherapeutics, Inc. is the new name for the company previously known as Synthetic Blood International, Inc. (OTCBB:SYBD). Effective with the opening of trading today, the company's new trading symbol will be OXBO. It will continue to trade on the Over-the-Counter Bulletin Board. "Our new name better reflects the broader scope of our development activities," said company chairman and CEO Chris J. Stern, DBA. "We have several exciting bio-therapeutic applications for...

2008-06-20 09:00:57

Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that grants awarded by the Department of Defense to study clinical applications for Oxycyte(R) total more than $5.3 million. Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier. The grants, which have been previously announced, are summarized below: -- Virginia Commonwealth University Reanimation Engineering Shock Center (VCURES) received $1.3 million under a previously awarded U.S. Office of...

2008-06-18 00:00:31

Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that the company's shareholders have approved the proposals put before them at a special shareholders meeting that was held today. The proposals include changing the name of the company to Oxygen Biotherapeutics, Inc. A new stock ticker symbol to go with the name change has not yet been designated. The name change will be made in connection with the approved reincorporation of the company and change in the company's...